Rajesh Rao, MD
Ophthalmology · Ann Arbor, MINPI 1780864884
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,840 of the $12,398 with a category attached, or 71.3%. Regeneron accounts for 95.3% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $10,551, more than ten times the $62 reported in 2019. Among ophthalmology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $399.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$12K
- AbbVie$305
- Carl Zeiss Meditec USA, Inc.$112
- Sight Sciences, Inc.$105
- Alcon$62
What the payments were for
- Consulting fees$8,84071%
- Travel & lodging$2,61421%
- Food & beverage$9448%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 24 | $11,815 |
| AbbVie | 4 | $305 |
| Carl Zeiss Meditec USA, Inc. | 1 | $112 |
| Sight Sciences, Inc. | 1 | $105 |
| Alcon | 1 | $62 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA HD$9,932
- ARTEVO 800$112
- OMNI(R) SURGICAL SYSTEM (US)$105
- OZURDEX$101
How this compares
$12,398 in reported general payments places this provider in the 90th percentile of 674 ophthalmology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 27 | $1,877 |
| Ketorolac Tromethamine | 30 | $910 |
| Brimonidine Tartrate | 12 | $826 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 27 | $542 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Ann Arbor
- Manjool ShahAnn Arbor$609K
- David ZacksAnn Arbor$177K
- Jason MillerAnn Arbor$104K
- Yannis PaulusAnn Arbor$85K
- Shilpa KodatiAnn Arbor$75K
- Amanda BicketAnn Arbor$34K
- Vinay AakaluAnn Arbor$16K
- Nita ValikodathAnn Arbor$16K
- Marguerite WeinertAnn Arbor$16K
- Abigail FahimAnn Arbor$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.